TerrAscend (TSNDF) Capital Expenditures (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Capital Expenditures of $865000.0 for Q1 2026, down 63.32% year-over-year from $2.4 million in Q1 2025, and down 49.59% quarter-over-quarter from $1.7 million in Q4 2025.
TerrAscend (TSNDF) Capital Expenditures (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Capital Expenditures for 6 consecutive years, with $865000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 63.32% year-over-year to $865000.0; the TTM figure through Mar 2026 stood at $7.1 million (up 10.78% YoY), while the FY2025 annual figure was $8.6 million, up 25.46% from the prior year.
- Capital Expenditures retreated to $865000.0 in Q1 2026 per TSNDF's latest filing, from $1.7 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $27.5 million in Q4 2022 and bottomed at -$2.0 million in Q2 2023.
- Historically, Capital Expenditures has averaged $3.6 million across 5 years, with a median of $2.2 million in 2025.
- Annual changes were most pronounced in 2023 — Capital Expenditures plunged 115.81% — and 2025, when it surged 13123.53%.
- TerrAscend's Capital Expenditures stood at $27.5 million in 2022, then slumped by 85.7% to $3.9 million in 2023, then dropped by 29.99% to $2.8 million in 2024, then plunged by 37.71% to $1.7 million in 2025, then tumbled by 49.59% to $865000.0 in 2026.
- Business Quant data shows TSNDF's Capital Expenditures at $865000.0 in Q1 2026, $1.7 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 1.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.64 Mn |
| Jun 30, 2026 | 1.64 Mn |
| Mar 31, 2026 | 865,000.00 |
| Mar 31, 2026 | 865,000.00 |
| Dec 31, 2025 | 1.72 Mn |
| Dec 31, 2025 | 1.72 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 2.36 Mn |
| Mar 31, 2025 | 2.36 Mn |
| Dec 31, 2024 | 2.76 Mn |
| Dec 31, 2024 | 2.76 Mn |
| Sep 30, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 2.80 Mn |
| Mar 31, 2024 | 2.80 Mn |